F. Mohammadzadeh, V. Hosseini, A. Alihemmati, A. Mehdizadeh, M. Shaaker, Gholamali Mosayyebi, M. Darabi
{"title":"The Role of Stearoyl-coenzyme A Desaturase 1 in Liver Development, Function, and Pathogenesis","authors":"F. Mohammadzadeh, V. Hosseini, A. Alihemmati, A. Mehdizadeh, M. Shaaker, Gholamali Mosayyebi, M. Darabi","doi":"10.15586/JRENHEP.2019.49","DOIUrl":null,"url":null,"abstract":"Stearoyl-coenzyme A desaturase 1 (SCD1) is a microsomal enzyme that controls fatty acid metabolism and is highly expressed in hepatocytes. SCD1 may play a key role in liver development and hepatic lipid homeostasis through promoting monounsaturated protein acylation and converting lipotoxic saturated fatty acids into monounsaturated fatty acids. Imbalanced activity of SCD1 has been implicated in fatty liver induction, inflammation and stress. In this review, the role of SCD1 in hepatic development, function and pathogenesis is discussed. Additionally, emerging novel therapeutic agents targeting SCD1 for the treatment of liver disorders are presented.","PeriodicalId":435887,"journal":{"name":"Journal of Renal and Hepatic Disorders","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Renal and Hepatic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15586/JRENHEP.2019.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
Stearoyl-coenzyme A desaturase 1 (SCD1) is a microsomal enzyme that controls fatty acid metabolism and is highly expressed in hepatocytes. SCD1 may play a key role in liver development and hepatic lipid homeostasis through promoting monounsaturated protein acylation and converting lipotoxic saturated fatty acids into monounsaturated fatty acids. Imbalanced activity of SCD1 has been implicated in fatty liver induction, inflammation and stress. In this review, the role of SCD1 in hepatic development, function and pathogenesis is discussed. Additionally, emerging novel therapeutic agents targeting SCD1 for the treatment of liver disorders are presented.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
